Cord stem cells could tame lupus in early trial
NCT ID NCT06737380
First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 33 times
Summary
This early study tests whether a single injection of stem cells from donated umbilical cords is safe for people with active lupus. Ten adults will receive the cells plus their usual care. Researchers will monitor side effects and check if the treatment improves kidney function and reduces disease activity.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Medical University of South Carolina
RECRUITINGCharleston, South Carolina, 29425, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
umbilical cord-derived mesenchymal stromal cells (UC-MSCs)
What this could lead to
If this works, it could point toward a new treatment option for lupus that helps control the disease and protect kidney function.
What could go wrong
This is a very early Phase 1 trial with only 10 people, so it is mainly checking safety, not effectiveness. The treatment may not work or could cause side effects.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.